Physician profile
Andrew Dockter
NPI 1255851077
$983.30
in general payments reported to CMS, 2019-2025
17 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2023: $144 · 2024: $429 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.86 | 2024 | |
| Amgen INC. | $190.69 | 2023-2025 | Evenity, Prolia, Prolia |
| Acell, INC. | $120.00 | 2019 | |
| Astellas Pharma US INC | $94.21 | 2024-2025 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $75.74 | 2023-2025 | Eliquis |
| Xeris Pharmaceuticals, INC. | $37.74 | 2024-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $36.64 | 2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $32.67 | 2025 | Trintellix |
| Actelion Pharmaceuticals US, INC. | $26.62 | 2024 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $24.63 | 2025 | Sapien 3 Ultra Resilia |
| Axsome Therapeutics, INC. | $22.44 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.62 | 2024 | Ofev |
| Merck Sharp & Dohme LLC | $19.45 | 2025 | Gardasil 9 |
| Lexicon Pharmaceuticals, INC. | $14.74 | 2023 | Inpefa |
| Dexcom, INC. | $13.77 | 2025 | Dexcom G6 Transmitter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.65 | 2023 | |
| Phathom Pharmaceuticals, INC. | $8.83 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dockter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.